Pulsenmore Ltd. stock fell in Friday’s premarket session after the company announced a $7.5 million private placement, extending a pullback that followed a sharp rally earlier this week. The Ramat Gan, Israel-based home ultrasound company entered into a securities purchase agreement with a single healthcare-focused institutional investor. The transaction is expected to close on Friday, subject to customary closing conditions.

Private Placement Details

The agreement includes the sale of 1,562,500 ordinary shares and warrants to purchase up to 1,562,500 additional ordinary shares at a combined price of $4.80 per share. Pulsenmore stated the offering price is above the Nasdaq minimum price required under exchange rules. The company expects gross proceeds of about $7.5 million before fees and expenses.

Use of Proceeds

Chief Executive Officer Elazar Sonnenschein said the financing will support the company’s next phase of growth by expanding its commercial presence, particularly in the U.S. market, increasing market penetration, and advancing strategic initiatives. Pulsenmore plans to use the net proceeds for marketing, commercialization activities, and general working capital.

Recent Stock Performance

The decline comes after Pulsenmore shares surged more than 200% in Wednesday’s premarket session following a partnership announcement with Ouma Health. The companies agreed to integrate Pulsenmore’s FDA-authorized home ultrasound platform into Ouma Health’s virtual maternity care model across the United States. Pulsenmore shares were down 9.41% at $5.345 during premarket trading on Friday.

Pulsenmore Ltd. has partnered with Ouma Health to integrate its FDA-authorized home ultrasound platform into Ouma's virtual maternity care solutions, addressing care gaps in underserved US communities where 35% of counties are classified as maternal care deserts. The collaboration aims to extend prenatal ultrasound monitoring into patients' homes, allowing clinicians to monitor pregnancies outside clinic hours while maintaining continuous connection between expectant mothers and their care teams. This integration supports a shift toward more connected, patient-centered care models.

Through the agreement, Ouma Health will incorporate Pulsenmore's technology to enable clinicians to monitor patients remotely. For Pulsenmore, the agreement represents a significant expansion of its presence in the US maternal health market, providing an opportunity to integrate its home ultrasound platform into an established virtual care model serving expectant mothers nationwide. Ouma Health provides virtual maternity care solutions for patients facing geographic and logistical barriers to prenatal care, including those in maternity deserts and underserved communities.

The partnership aims to deliver transformative care for underserved patients and establish insights to support future expansion with healthcare systems and payer organizations. Home ultrasound is emerging as a key component of virtual and hybrid prenatal care models, helping providers improve access and patient engagement.

"Maternal healthcare is undergoing a fundamental transformation toward more connected, patient-centered care models," said Dr. Elazar Sonnenschein, Founder and CEO of Pulsenmore. "By partnering with Ouma Health, we have an opportunity to bring ultrasound beyond the walls of the clinic and into established virtual maternity care pathways, helping healthcare professionals expand access to prenatal monitoring while keeping patients at the center of care."

Dr. Sina Haeri, CEO of Ouma Health, emphasized the impact on patients facing geographic and logistical barriers. "At Ouma, we care for patients who often face significant geographic and logistical barriers to prenatal care, including those living in maternity deserts and underserved communities. Pulsenmore's technology gives us a way to bring more of the prenatal monitoring experience into the home, while keeping patients connected to a clinical team that can review the information and guide next steps."

Following the announcement, Pulsenmore shares rose 204.16% to $10.37 in premarket trading on Wednesday.